Longer TA repeat but not V89L polymorphisms in the SRD5A2 gene may confer acne risk in the Chinese population

被引:2
|
作者
Hu, Xue [1 ]
Ding, Wei [2 ]
Jin, Xinye [3 ]
Wang, Jia [4 ]
Zou, Dajin [5 ]
Chen, Yue [6 ]
机构
[1] Shidong Hosp, Dept Endocrinol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Geriatr, Shanghai, Peoples R China
[3] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China
[4] Gen Hosp Jinan Mil Reg Chinese Peoples Liberat Ar, Dept Endocrinol, Jinan, Shandong, Peoples R China
[5] Second Mil Med Univ, Dept Endocrinol, Changhai Hosp, 168 ChangHai Rd, Shanghai 200433, Peoples R China
[6] Shanghai Baoshan Tradit Chinese Med Integrated Ho, Dept Endocrinol, 181 YouYi Rd, Shanghai 201900, Peoples R China
来源
POSTEPY DERMATOLOGII I ALERGOLOGII | 2018年 / 35卷 / 01期
关键词
acne; SRD5A2; gene; V89L polymorphism; (TA)n repeat polymorphism; PROSTATE-CANCER RISK; STEROID; 5-ALPHA-REDUCTASE; ASSOCIATION; TYPE-2;
D O I
10.5114/ada.2018.73162
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Introduction: Several studies have reported that the V89L and TA repeat polymorphisms [(TA)n] of the SRD5A2 gene were associated with SRD5A2 activity. The activity of dihydrotestosterone, which is converted from testosterone by SRD5A2, is responsible for sebum secretion and the formation of acne. We hypothesized that abnormalities in SRD5A2 action could contribute to the formation of acne. Aim: To study whether the structural change of the SRD5A2 gene may affect the risk of acne in patients with normal serum testosterone levels. Material and methods: Genotyping of rs523349 and (TA) n of SRD5A2 was performed in 49 Chinese acne patients with significant improvements with SRD5A2 inhibitor-finasteride but normal serum testosterone levels, and in 50 healthy Chinese age-matched controls without acne. Results: There was no significant difference between the two groups in the frequencies of V and L alleles and VV, VL, and LL genotypes of V89L (chi(2) test, p > 0.5). (TA) n polymorphic repeat sites are 5 alleles (TA0, TA3, TA6, TA9, TA12) in our population. The differences in S and L allele frequencies between the two groups were statistically significant (p < 0.005). People with a longer (n >= 6) allele of the (TA) n repeat polymorphism had a higher risk of having acne than those with a shorter (n < 6) allele (OR = 3.52, 95% CI: 1.73-7.16). Conclusions: This study suggests that SRD5A2 polymorphisms might be associated with acne risk. This is the first report focusing on the Chinese population according to our knowledge. Further large sample studies may be required to confirm the association and to assess any interactions with environmental factors.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 47 条
  • [21] The V89L polymorphism in the 5-α-reductase type 2 gene and risk of breast cancer
    van Gils, CH
    Onland-Moret, NC
    Roest, M
    van Noord, PAH
    Peeters, PHM
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1194 - 1199
  • [22] V89L(rs523349) and A49T(rs9282858) variations on SRD5A2 gene on dutasteride efficacy and safety in bladder cancer patients: A pilot study
    Incir, C.
    Gumustekin, M.
    Korhan, P.
    Ozer, M.
    Sarikaya, A.
    Bozkurt, O.
    Atabey, N.
    Esen, A.
    Tuncok, Y.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S99 - S100
  • [23] The Association of SRD5A2 Gene Polymorphism at Codon 89 and Prostate Cancer Risk: Case Control Study
    Dusenka, R.
    Tomaskin, R.
    Grobarcikova, S.
    Sivonova, Kmetova M.
    Dobrota, D.
    Kliment, J.
    UROLOGY, 2012, 80 (03) : S82 - S83
  • [24] Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk:: An explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors
    Cussenot, Oliuier
    Azzouzi, Abdel-Rahmene
    Nicolaiew, Nathalie
    Mangin, Philippe
    Cormier, Luc
    Fournier, Georges
    Valeri, Antoine
    Cancel-Tassin, Geraldine
    EUROPEAN UROLOGY, 2007, 52 (04) : 1082 - 1089
  • [25] The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population
    Choi, Se Young
    Kim, Hae Jong
    Cheong, Hyun Sub
    Myung, Soon Chul
    KOREAN JOURNAL OF UROLOGY, 2015, 56 (01) : 19 - 29
  • [26] Steroid 5-α-Reductase Type 2 (SRD5a2) Gene Polymorphisms and Risk of Prostate Cancer: A HuGE Review
    Li, Jun
    Coates, Ralph J.
    Gwinn, Marta
    Khoury, Muin J.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 (01) : 1 - 13
  • [27] A49T, V89L and TA repeat polymorphisms of steroid 5α-reductase type II and breast cancer risk in Japanese women -: art. no. R8
    Yang, CX
    Hamajima, N
    Iwata, H
    Saito, T
    Matsuo, K
    Hirose, K
    Inoue, M
    Takezaki, T
    Tajima, K
    BREAST CANCER RESEARCH, 2002, 4 (04):
  • [28] Association of V89L SRD5A polymorphism and prostate cancer development in a Japanese population (vol 169 pg 2378, 2002)
    Kinoshita, H
    JOURNAL OF UROLOGY, 2003, 170 (05): : 1957 - 1957
  • [29] The valine allele of the V89L polymorphism in the 5-α-reductase gene confers a reduced risk for hypospadias
    Thai, HTT
    Kalbasi, M
    Lagerstedt, K
    Frisén, L
    Kockum, I
    Nordenskjöld, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12): : 6695 - 6698
  • [30] The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population EDITORIAL COMMENT
    Yun, Seok Joong
    KOREAN JOURNAL OF UROLOGY, 2015, 56 (01) : 29 - 30